番茄社区

Risks include visually threatening infections, inflammatory issues, pigment migration

In the third year, 88% of patients could go 12 weeks or longer with 8-mg dose

Delegates express concerns that PPE doesn't always cover women, who are more at risk of exposure

Peter K. Kaiser, MD, leads a discussion about the presentation given by Yasha S. Modi, MD, at AAO

Members also debate alternative ways states can safely license foreign med-school graduates

Ophthalmologists hope expanded use will lead to more evaluations in primary clinics

Valeda photobiomodulation system slowed disease progression and improved vision

Peter K. Kaiser, MD, leads a discussion from the AAO meeting

Retired physician Jay Berger, MD, reportedly suffered a mental health crisis

Provision in drug act would prohibit repackaging Avastin, add millions to anti-VEGF therapy cost

Significant improvement beyond 100 weeks after single injection of mutation-agnostic MCO-010

Three cycles could become the new standard for retinoblastoma, researchers say

Drug targeting junctional zone reduces GA growth by 48% in 3 months, oral agent moderately active

Study suggests potential to eliminate a third of in-office visits without harming care